Moreover, we compared findings in bOE with findings in unilaterally removed, pathohistologically confirmed GCTs (GCT-uOE) and therefore hypothesized that clinically unremarkable ovaries of bOE are differentiated from neoplastic changes in GCT-uOE by means of the immunohistochemical markers Ki67, AMH, AR, EGFR, CAL, and E-Cad. This evidence concerns the gene MKI67 and granular cell tumor.